Teleflex Incorporated (NYSE:TFX) Receives $144.00 Consensus Price Target from Analysts

Teleflex Incorporated (NYSE:TFX) has been assigned an average recommendation of “Hold” from the nine analysts that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $144.00.

Several brokerages recently commented on TFX. Wall Street Zen cut Teleflex from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Zacks Research upgraded Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Mizuho set a $140.00 price target on Teleflex in a research report on Friday, May 8th. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a report on Friday, March 27th. Finally, Wells Fargo & Company raised their target price on Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th.

Teleflex Stock Up 0.0%

Shares of TFX opened at $129.90 on Wednesday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. Teleflex has a one year low of $100.18 and a one year high of $139.67. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of -5.70, a PEG ratio of 0.97 and a beta of 0.82. The stock has a 50 day moving average price of $127.08 and a 200 day moving average price of $118.14.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same period in the previous year, the business earned $1.44 earnings per share. The firm’s revenue for the quarter was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts forecast that Teleflex will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s payout ratio is presently -5.96%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of TFX. Empowered Funds LLC boosted its position in shares of Teleflex by 15.8% during the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after acquiring an additional 230 shares during the last quarter. Jane Street Group LLC boosted its position in shares of Teleflex by 42.6% during the 1st quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after acquiring an additional 1,895 shares during the last quarter. American Century Companies Inc. boosted its position in shares of Teleflex by 32.7% during the 2nd quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock valued at $1,614,000 after acquiring an additional 3,360 shares during the last quarter. Invesco Ltd. boosted its position in shares of Teleflex by 1.2% during the 2nd quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock valued at $16,040,000 after acquiring an additional 1,659 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in shares of Teleflex by 108.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock valued at $119,000 after purchasing an additional 521 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.